Tseng‐Hsi Lin

589 total citations
19 papers, 480 citations indexed

About

Tseng‐Hsi Lin is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Tseng‐Hsi Lin has authored 19 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Surgery. Recurrent topics in Tseng‐Hsi Lin's work include Retinoids in leukemia and cellular processes (3 papers), Colorectal Cancer Treatments and Studies (2 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Tseng‐Hsi Lin is often cited by papers focused on Retinoids in leukemia and cellular processes (3 papers), Colorectal Cancer Treatments and Studies (2 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Tseng‐Hsi Lin collaborates with scholars based in Taiwan and United States. Tseng‐Hsi Lin's co-authors include Hsing‐Chun Kuo, Fung‐Jou Lu, Fen‐Pi Chou, Shu‐Chen Chu, Yih‐Shou Hsieh, Yen-Chang Hsiao, Cheng‐Nan Chen, Chien‐Hsiang Weng, Horng‐Rong Chang and Chien‐Heng Shen and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Toxicology.

In The Last Decade

Tseng‐Hsi Lin

19 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tseng‐Hsi Lin Taiwan 13 187 82 80 67 58 19 480
Ki‐Baik Hahm South Korea 15 172 0.9× 78 1.0× 78 1.0× 73 1.1× 46 0.8× 21 580
Jasmin Shafarin United Arab Emirates 16 305 1.6× 69 0.8× 63 0.8× 52 0.8× 111 1.9× 37 653
Anna‐Lena Mueller Germany 10 234 1.3× 61 0.7× 52 0.7× 36 0.5× 63 1.1× 15 579
Masayoshi Fujisawa Japan 12 358 1.9× 105 1.3× 41 0.5× 79 1.2× 111 1.9× 53 751
Mengmeng Dou China 15 322 1.7× 70 0.9× 83 1.0× 38 0.6× 108 1.9× 31 597
Linan Zhao China 11 201 1.1× 65 0.8× 39 0.5× 44 0.7× 58 1.0× 25 495
Youra Kang South Korea 13 272 1.5× 89 1.1× 102 1.3× 56 0.8× 46 0.8× 27 579
Da‐Yong Cao China 13 296 1.6× 106 1.3× 51 0.6× 48 0.7× 110 1.9× 20 591
Yung-Wei Lin Taiwan 13 269 1.4× 69 0.8× 40 0.5× 70 1.0× 68 1.2× 25 475
Maleppillil Vavachan Vijayakumar India 11 246 1.3× 134 1.6× 50 0.6× 78 1.2× 114 2.0× 14 590

Countries citing papers authored by Tseng‐Hsi Lin

Since Specialization
Citations

This map shows the geographic impact of Tseng‐Hsi Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tseng‐Hsi Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tseng‐Hsi Lin more than expected).

Fields of papers citing papers by Tseng‐Hsi Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tseng‐Hsi Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tseng‐Hsi Lin. The network helps show where Tseng‐Hsi Lin may publish in the future.

Co-authorship network of co-authors of Tseng‐Hsi Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Tseng‐Hsi Lin. A scholar is included among the top collaborators of Tseng‐Hsi Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tseng‐Hsi Lin. Tseng‐Hsi Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Weng, Chien‐Huan, et al.. (2019). Association Between Thyroid Disorders and Colorectal Cancer Risk in Adult Patients in Taiwan. JAMA Network Open. 2(5). e193755–e193755. 24 indexed citations
2.
Lin, Chun‐Yu, et al.. (2018). Combination chemotherapy with Regorafenib in metastatic colorectal cancer treatment: A single center, retrospective study. PLoS ONE. 13(1). e0190497–e0190497. 14 indexed citations
3.
Weng, Chien‐Hsiang, Yi-Huei Chen, Ching‐Heng Lin, Xun Luo, & Tseng‐Hsi Lin. (2018). Thyroid disorders and breast cancer risk in Asian population: a nationwide population-based case–control study in Taiwan. BMJ Open. 8(3). e020194–e020194. 24 indexed citations
4.
Wu, Ming‐Feng, et al.. (2018). Effects of Analyzer Detection Method, Ethnicity, and Reference Individuals on Reference Interval of Immature Platelet Fraction. Clinical Laboratory. 64(05/2018). 699–708. 2 indexed citations
5.
Weng, Chien‐Hsiang, Ren‐Ching Wang, Cheng-Chung Wu, & Tseng‐Hsi Lin. (2016). Treatment of synchronous adenocarcinoma and lymphoma of the stomach: A case report. Molecular and Clinical Oncology. 5(6). 783–785. 6 indexed citations
6.
Chiu, Chien‐Shan, et al.. (2015). Vemurafenib-associated neutrophilic panniculitis in a patient with metastatic amelanotic melanoma presenting as cancer of unknown primary origin. Dermatologica Sinica. 34(2). 88–91. 1 indexed citations
7.
Tseng, Tsui‐Hwa, Chien‐Heng Shen, Wen‐Shih Huang, et al.. (2014). Activation of neutral-sphingomyelinase, MAPKs, and p75 NTR-mediating caffeic acid phenethyl ester–induced apoptosis in C6 glioma cells. Journal of Biomedical Science. 21(1). 61–61. 30 indexed citations
8.
Shen, Chien‐Heng, Shui‐Yi Tung, Wen‐Shih Huang, et al.. (2014). Exploring the effects of tert-butylhydroperoxide induced liver injury using proteomic approach. Toxicology. 316. 61–70. 19 indexed citations
9.
Hsieh, Yung‐Yu, Chien‐Heng Shen, Wen‐Shih Huang, et al.. (2014). Resistin-induced stromal cell-derived factor-1 expression through Toll-like receptor 4 and activation of p38 MAPK/ NFκB signaling pathway in gastric cancer cells. Journal of Biomedical Science. 21(1). 59–59. 68 indexed citations
10.
Chang, Li‐Ching, Hsing‐Chun Kuo, Shun‐Fu Chang, et al.. (2013). Regulation of ICAM-1 expression in gingival fibroblasts infected with high-glucose-treatedP. gingivalis. Cellular Microbiology. 15(10). n/a–n/a. 14 indexed citations
11.
Weng, Chien‐Hsiang, Tseng‐Hsi Lin, Tsu‐Yi Hsieh, Che-An Tsai, & Ren‐Ching Wang. (2012). Penicillium Pneumonia in a Patient With Newly Diagnosed Franklin Disease. The American Journal of the Medical Sciences. 344(1). 69–71. 4 indexed citations
12.
Weng, Chien‐Hsiang, et al.. (2011). Surgically Curable Non-Iron Deficiency Microcytic Anemia: Castleman’s Disease. Onkologie. 34(8). 456–458. 11 indexed citations
13.
Chen, Te‐Chuan, Shao‐Ju Chien, Hsing‐Chun Kuo, et al.. (2011). High Glucose-treated Macrophages Augment E-Selectin Expression in Endothelial Cells. Journal of Biological Chemistry. 286(29). 25564–25573. 17 indexed citations
14.
Lin, Tseng‐Hsi, Fung‐Jou Lu, Yufang Yin, & Tsui‐Hwa Tseng. (2009). Enhancement of esculetin on arsenic trioxide-provoked apoptosis in human leukemia U937 cells. Chemico-Biological Interactions. 180(1). 61–68. 12 indexed citations
15.
Chen, Kuo-Shuen, Yen-Chang Hsiao, Dong‐Yih Kuo, et al.. (2008). Tannic acid-induced apoptosis and -enhanced sensitivity to arsenic trioxide in human leukemia HL-60 cells. Leukemia Research. 33(2). 297–307. 45 indexed citations
16.
Lin, Tseng‐Hsi, Hsing‐Chun Kuo, Fen‐Pi Chou, & Fung‐Jou Lu. (2008). Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide. BMC Cancer. 8(1). 58–58. 76 indexed citations
17.
Chen, Chih‐Cheng, et al.. (2008). Prospective, randomized, controlled trial of tranexamic acid in patients who undergo head and neck procedures. Otolaryngology. 138(6). 762–767. 19 indexed citations
18.
Hsiao, Yen-Chang, Wu‐Hsien Kuo, Pei‐Ni Chen, et al.. (2007). Flavanone and 2′-OH flavanone inhibit metastasis of lung cancer cells via down-regulation of proteinases activities and MAPK pathway. Chemico-Biological Interactions. 167(3). 193–206. 90 indexed citations
19.
Teng, Chieh‐Lin Jerry, et al.. (2005). Rapidly fatal Langerhans' cell histiocytosis in an adult.. PubMed. 104(12). 955–9. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026